在细胞因子风暴综合征中IL-1家族封锁
1Children's of Alabama, Birmingham, AL, USA. randycron@uabmc.edu.
Advances in experimental medicine and biology
|August 8, 2024
概括
介素-1 (IL-1) 和相关的细胞因子与细胞因子风暴综合征 (CSS) 有关. 准IL-1及其家族成员对治疗这些严重的炎症状况有希望.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞因子生物学 细胞因子生物学
- 炎症研究 炎症研究
背景情况:
- 干白素-1 (IL-1) 是一种关键的促炎性细胞因子,在细胞因子风暴综合征 (CSS) 中升高,包括二次血细胞淋巴细胞化 (sHLH) 和巨细胞激活综合征 (MAS).
- IL-1在先天性和适应性免疫中发挥着不同的作用,其与IL-1受体对手的阻断在治疗CSS中是有效的.
- 其他IL-1家族成员,如IL-18和IL-33,也涉及到CSS的发病,其中IL-18在自身炎症条件和动物模型中的IL-33中显示出贡献.
研究的目的:
- 审查介素-1 (IL-1) 和相关细胞因子在细胞因子风暴综合征 (CSS) 病原发生中的作用.
- 突出针对IL-1及其家族成员管理CSS的治疗潜力.
主要方法:
- 在CSS中研究IL-1和相关细胞因子的文献综述.
- 对IL-1阻断在CSS治疗中的有效性临床数据的分析.
- 检查IL-18和IL-33参与CSS的证据.
主要成果:
- 升高的IL-1水平是CSS的特征,而IL-1阻断证明了治疗疗效.
- 在自身炎症条件下,IL-18有助于CSS,IL-18结合蛋白可能会带来好处.
- 动物模型研究表明,IL-33与CSS有关.
结论:
- 准IL-1和相关的细胞因子为各种细胞因子风暴综合征提供了一个有希望的治疗策略.
- 对IL-1家族成员的进一步研究可能会导致CSS的新治疗方法.
关键词:
这就是阿纳金拉.细胞因子风暴综合征 细胞因子风暴综合征它是IL-1受体对抗剂.这是一种IL-18结合蛋白.介质蛋白-1 (IL-1) 介质蛋白-1 (IL-1) 介质蛋白-1 (IL-1) 介质蛋白-1 (IL-1) 介质蛋白-1) 介质蛋白-1 (IL-1) 介质蛋白-1 (IL-1) 介质蛋白-1 (IL-1) 介质蛋白-1) 介质蛋白-1 (IL-1) 介质蛋白-1互乐金-1受体类似的 1 1介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18) 介质蛋白-18 (IL-18)介质蛋白-33 (IL-33) 是一种蛋白质.巨细胞激活综合征是什么二次性血细胞性淋巴细胞化.相关概念视频
T Cell Types and Functions
966
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
966
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K


